Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation - Authors' reply

Affiliations

¹ Disciplines of Medical Oncology, Melanoma Institute Australia, University of Sydney, Sydney, NSW 2065, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. Electronic address: georgina.long@sydney.edu.au.
² Princess Alexandra Hospital, University of Queensland, Brisbane, QLD, Australia.
³ Radiation Oncology, Melanoma Institute Australia, University of Sydney, Sydney, NSW 2065, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.
⁴ Peter MacCallum Cancer Centre and Medical, Dental and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
⁵ Disciplines of Medical Oncology, Melanoma Institute Australia, University of Sydney, Sydney, NSW 2065, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.

Comment

Georgina V Long et al. Lancet Oncol. 2018 Aug.

. 2018 Aug;19(8):e367.

doi: 10.1016/S1470-2045(18)30508-4.

¹ Disciplines of Medical Oncology, Melanoma Institute Australia, University of Sydney, Sydney, NSW 2065, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. Electronic address: georgina.long@sydney.edu.au.
² Princess Alexandra Hospital, University of Queensland, Brisbane, QLD, Australia.
³ Radiation Oncology, Melanoma Institute Australia, University of Sydney, Sydney, NSW 2065, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.
⁴ Peter MacCallum Cancer Centre and Medical, Dental and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
⁵ Disciplines of Medical Oncology, Melanoma Institute Australia, University of Sydney, Sydney, NSW 2065, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.

No abstract available

Comment on

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.
Long GV, Atkinson V, Lo S, Sandhu S, Guminski AD, Brown MP, Wilmott JS, Edwards J, Gonzalez M, Scolyer RA, Menzies AM, McArthur GA. Long GV, et al. Lancet Oncol. 2018 May;19(5):672-681. doi: 10.1016/S1470-2045(18)30139-6. Epub 2018 Mar 27. Lancet Oncol. 2018. PMID: 29602646 Clinical Trial.
Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation.
Kruser TJ, Gondi V, Sperduto PW, Brown PD, Mehta MP. Kruser TJ, et al. Lancet Oncol. 2018 Aug;19(8):e366. doi: 10.1016/S1470-2045(18)30439-X. Lancet Oncol. 2018. PMID: 30102216 No abstract available.